BioNTech SE (NASDAQ: BNTX) reported Q4 EPS of EUR1.08. Revenue for the quarter came in at EUR1.19 billion versus the consensus estimate of EUR1.12 billion.

GUIDANCE:

BioNTech SE sees FY2025 revenue of EUR1.7-2.2 billion.

For earnings history and earnings-related data on BioNTech SE (BNTX) click here.